Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
05/2014
05/20/2014CA2448567C Modulators of nucleic acid ligands
05/15/2014WO2014074848A1 Therapeutic compounds and compositions and their use as pkm2 modulators
05/15/2014WO2014074805A1 Selective targeting of cancer stem cells
05/15/2014WO2014074700A1 Antagonists of gpr119 receptor and the treatment of disorders related thereto
05/15/2014WO2014074670A1 ALKYL AMIDE-SUBSTITUTED PYRIMIDINE COMPOUNDS USEFUL IN THE MODULATION OF IL-12, IL-23 AND/OR IFNα
05/15/2014WO2014074665A1 Macrocyclic compounds for inhibition of inhibitors of apoptosis
05/15/2014WO2014074660A1 ALKYL-AMIDE-SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFNα RESPONSES
05/15/2014WO2014074658A1 Macrocyclic compounds for inhibition of inhibitors of apoptosis
05/15/2014WO2014074657A1 Bicyclic heterocycle substituted pyridyl compounds useful as kinase modulators
05/15/2014WO2014074584A1 On-demand drug release using magneto-electric nanoparticles
05/15/2014WO2014074580A1 Combination therapy
05/15/2014WO2014073989A1 Salt and polymorphic forms of (3r,4s)-l-((4-amino-5h-pyrrolo[3,2-d]pyrimidin-7-yl)methyl)-4(methylthiomethyl)pyrodin-3-ol(mtdia)
05/15/2014WO2014073740A1 Anti-cancer drug and treatment method for treating tumors having multidrug resistance
05/15/2014WO2014073641A1 Antibody capable of specifically recognizing transferrin receptor
05/15/2014WO2014073447A1 Polymeric compound having camptothecin compound and anti-cancer effect enhancer bound thereto, and use of same
05/15/2014WO2014073292A1 Anti-adam28 antibody for treating cancer
05/15/2014WO2014072985A1 Novel boronic acid derivatives as anti cancer agents
05/15/2014WO2014072967A1 Drug combination comprising a glycolysis inhibitor and a tyrosine kinase inhibitor
05/15/2014WO2014072956A1 Oxazolidin-2-one-pyrimidine derivatives
05/15/2014WO2014072940A1 Inhibitor of integrin for the treatment or prevention of tumours
05/15/2014WO2014072714A1 Novel histone deacetylase inhibitors and their use in therapy
05/15/2014WO2014072700A1 Ly75 as cancer therapeutic and diagnostic target
05/15/2014WO2014072493A1 Pharmaceutical combination comprising a b-raf inhibitor and a histone deacetylase inhibitor and their use in the treatment of proliferative diseases
05/15/2014WO2014072486A1 New benzene sulfonamide thiazole compounds
05/15/2014WO2014072468A1 Compositions for pulmonary delivery
05/15/2014WO2014072416A1 Methods and pharmaceutical compositions for the treatment of bone metastases
05/15/2014WO2014072371A1 Indole derivatives, pharmaceutical compositions containing such indoles and their use as dna methylation modulators
05/15/2014WO2014072357A1 Combination for use in treating diseases or conditions associated with melanoma, or treating diseases or conditions associated with activated b-raf pathway
05/15/2014WO2014072305A1 Anti-her3/her4 antigen binding proteins binding to the beta-hairpin of her3 and the beta-hairpin of her4
05/15/2014WO2014072277A1 Formulation for bispecific t-cell engagers (bites)
05/15/2014WO2014072244A1 Sulfoximine substituted quinazolines for pharmaceutical compositions
05/15/2014WO2014072220A1 Substituted pyrimidinyl and pyridinyl-pyrrolopyridinones, process for their preparation and their use as kinase inhibitors
05/15/2014WO2014071892A1 Lamin a, an activator of longevity/anti-aging sirt1 protein
05/15/2014WO2014071863A1 Use of benzonitrile compounds in preparing medicaments for treating tumor
05/15/2014WO2014071832A1 Alk kinase inhibitors
05/15/2014WO2014071824A1 4-quinazolinamine heterocyclic compound and use thereof
05/15/2014WO2014071531A1 Aprotinin-derived polypeptide-antibody conjugates
05/15/2014WO2014071438A1 Modified polyphenols and modified polyphenol compositions
05/15/2014WO2014047232A3 C-rel inhibitors and uses thereof
05/15/2014WO2014031204A3 Carbohydrate-selective receptors
05/15/2014US20140135487 Immunostimulatory g, u-containing oligoribonucleotides
05/15/2014US20140135384 Endogenous retrovirus polypeptides linked to oncogenic transformation
05/15/2014US20140135340 High Drug Load Tablet
05/15/2014US20140134182 Antibodies of the ed-b domain of fibronectin, their construction and uses
05/15/2014US20140134164 Treatment of multiple sclerosis
05/15/2014DE102013107024A1 Methoden und Zusammensetzungen zum Behandeln, Modifizieren und Handhaben von Knochenkrebsschmerz Methods and compositions for treating, modifying and manipulating bone cancer pain
05/14/2014EP2730581A1 Boronate ester compounds and pharmaceutical compositions thereof
05/14/2014EP2730580A1 Boronate ester compounds and pharmaceutical compositions thereof
05/14/2014EP2730579A1 Boronate ester compounds and pharmaceutical compositions thereof
05/14/2014EP2730565A1 Tumor targeted drug combretastatin a4 derivative
05/14/2014EP2730558A1 Indole derivatives, pharmaceutical compositions containing such indoles and their use as DNA methylation modulators
05/14/2014EP2729605A1 Rna-yy1 interactions
05/14/2014EP2729467A1 Cryptate compounds
05/14/2014EP2729466A1 Novel pyrrolo pyrimidine derivatives
05/14/2014EP2729459A1 Substituted azaheterocycles for the treatment of cancer
05/14/2014EP2729450A1 N- (2 -aminophenyl) benzamide derivatives as histone deacetylase inhibitors
05/14/2014EP2729185A1 Method of treating cholangiocarcinoma and apparatus
05/14/2014EP2729183A1 Enhanced in vivo targeting of radiolabelled peptides with the means of enzyme inhibitors
05/14/2014EP2729180A2 Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
05/14/2014EP2729170A2 Antibody variants and uses thereof
05/14/2014EP2729166A2 Cancer antigen
05/14/2014EP2729146A1 Medicament for treatment of liver cancer
05/14/2014EP2729144A2 Treating cancer with hsp90 inhibitory compounds
05/14/2014CN1918162B 新的稠合吡咯并咔唑类化合物 New pyrrolocarbazole fused compounds
05/14/2014CN103797012A 新的酶抑制剂化合物 The new inhibitor compounds
05/14/2014CN103797010A 作为jak抑制剂的氮杂环丁烷基苯基、吡啶基或吡嗪基甲酰胺衍生物 As jak inhibitor azetidin alkylphenyl, pyridyl or pyrazinyl carboxamide derivatives
05/14/2014CN103796680A 用于增强针对赘生物的基于免疫的治疗的聚焦放射 Used to enhance immune-based therapy focuses radiation for vegetation
05/14/2014CN103796678A 针对her2的双特异性抗体 Bispecific antibodies against the her2
05/14/2014CN103796677A 针对her2和cd3的双特异性抗体 For her2 and cd3 bispecific antibody
05/14/2014CN103796654A 氘富集化4-羟基-5-甲氧基-n,1-二甲基-2-氧代-n-[(4-三氟-甲基)苯基]-1,2-二氢喹啉-3-甲酰胺 Deuterium enrichment of 4-hydroxy-5-methoxy -n, 1- dimethyl-2-oxo -n - [(4- - trifluoro-methyl) phenyl] -1,2-dihydroquinoline morpholine-3-carboxamide
05/14/2014CN103796647A 用于治疗脑癌的方法和组合物 A method for the treatment of brain cancer and compositions
05/14/2014CN103789347A 一种下调微小rna-7表达的载体及其应用 A tiny cut rna 7-expression vector and its application
05/14/2014CN103789309A 一种长链非编码RNA lncRNA-BcrAR及其在抗细胞癌变中的应用 A long chain of non-coding RNA lncRNA-BcrAR its application in anti-carcinogenesis in
05/14/2014CN103789136A 一种发酵型枸杞红枣米酒及其制备方法 Wolfberry jujube rice wine fermented type and preparation method
05/14/2014CN103788683A 一种镰刀霉菌色素的制备方法 Preparation method of Fusarium pigment
05/14/2014CN103788366A 单甲氧基聚乙二醇-二硫-二维生素e琥珀酸酯及其制备和应用 Single-methoxy polyethylene glycol - disulfide - two vitamin e succinate and preparation and application
05/14/2014CN103788361A 7-乙基-10-羟基喜树碱长循环脂质体的制备方法 Preparation of 7-ethyl-10-hydroxycamptothecin long-circulating liposomes
05/14/2014CN103788232A 一种硫酸乙酰肝素十糖及其制备方法和应用 A sulfated heparan decasaccharide its preparation method and application
05/14/2014CN103788229A 一种从金针菇中同时提取多糖和多酚的方法 A method of simultaneously extracted from the mushroom polysaccharides and polyphenols in
05/14/2014CN103788213A 一种gm-csf-tat-cea重组蛋白及其方法和应用 One kind of gm-csf-tat-cea recombinant protein and methods and applications
05/14/2014CN103788212A 双特异性抗原结合蛋白复合物以及制备双特异性抗体的方法 Bispecific antigen binding protein complex and a process for the preparation of bispecific antibodies
05/14/2014CN103788211A 双功能肽、所述双功能肽与核酸分子形成的复合物以及治疗肿瘤的药物组合物 Bifunctional peptides, the peptide complexes of the bifunctional molecules to form a nucleic acid and a pharmaceutical composition for the treatment of tumors
05/14/2014CN103788192A 中华大蟾蜍抗菌肽bg-cath6(29)及其编码基因和应用 Bufo antimicrobial peptide bg-cath6 (29) and its coding gene and application
05/14/2014CN103788180A 中华大蟾蜍抗菌肽bg-lw18及其编码基因和应用 Bufo antimicrobial peptide bg-lw18 its coding gene and application
05/14/2014CN103788166A △<sup>13（18）</sup>-CDDO衍生物、其制备方法与在制药中的用途 △ <sup> 13 (18) </ sup> -CDDO derivatives, their preparation and use in pharmacy
05/14/2014CN103788165A 阿糖胞苷胆酸结合物及其制备方法和用途 Ara acid conjugates and their preparation and use
05/14/2014CN103788159A 阿维菌素B<sub>1a</sub>荧光标记物及其应用 1a </ sub> fluorescent marker avermectin B <sub> and Its Applications
05/14/2014CN103788141A 硫酸化寡聚糖衍生物 Sulfated oligosaccharides derivatives
05/14/2014CN103788139A 具抗癌活性的昆布氨酸希夫碱异双核配合物的合成及其药物组合物 Synthesis of laminin with anticancer activity Heterobinuclear Schiff base complexes and pharmaceutical compositions thereof
05/14/2014CN103788134A 一种微波辅助炔基修饰钌(Ⅱ)配合物的制备方法及其应用 A microwave-assisted alkyne-modified ruthenium (Ⅱ) complex and its application preparation thereof
05/14/2014CN103788128A 一种有机膦四核铜配合物及其制备方法和应用 An organic phosphine complexes quad-core copper and its preparation method and application
05/14/2014CN103788118A 单核铜配合物及其制备方法和应用 Mononuclear copper complex and its preparation method and application
05/14/2014CN103788109A 一种倍半萜类化合物及其制备方法和用途 A sesquiterpene compounds and their preparation and use
05/14/2014CN103788108A 氧杂双环庚烷和氧杂双环庚烯，它们的制备及用途 Oxabicyclo oxabicyclo heptane and heptene, their preparation and use
05/14/2014CN103788103A 氘代二甲基胺小白菊内酯,其制备方法和在制备药物中的用途 Deuterated dimethyl amine parthenolide, their preparation and use in the manufacture of a medicament
05/14/2014CN103788100A 作为cdk抑制剂的吡咯并嘧啶化合物 As cdk inhibitors pyrrolo pyrimidine compounds
05/14/2014CN103788085A 2-（喹唑啉-4-氨基）-5-噻唑甲酰胺类衍生物及其生物药物用途 2- (quinazolin-4-amino) -5-thiazole-carboxamide derivatives and pharmaceutical use of biological
05/14/2014CN103788075A 一种胸苷磷酸化酶抑制剂的结晶形式及其制备方法 A crystalline form and a preparation method of thymidine phosphorylase inhibitors
05/14/2014CN103788071A N-(5-(喹啉-6-基)吡啶-3-基)苯磺酰胺衍生物、制备方法及治疗用途 N- (5- (quinolin-6-yl) pyridin-3-yl) benzenesulfonamide derivatives, a preparation method and the therapeutic use of
05/14/2014CN103788053A 布雷菲德菌素a酯类衍生物及其制备与应用 Brefeldin a ester derivatives, preparation and application
1 ... 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 ... 2211